Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Two p53 tetramers bind one consensus DNA response element.

Kearns S, Lurz R, Orlova EV, Okorokov AL.

Nucleic Acids Res. 2016 Jul 27;44(13):6185-99. doi: 10.1093/nar/gkw215. Epub 2016 Mar 31.

2.

The p53 circuit board.

Sullivan KD, Gallant-Behm CL, Henry RE, Fraikin JL, Espinosa JM.

Biochim Biophys Acta. 2012 Apr;1825(2):229-44. doi: 10.1016/j.bbcan.2012.01.004. Epub 2012 Feb 7. Review.

3.

p53 requires an intact C-terminal domain for DNA binding and transactivation.

Kim H, Kim K, Choi J, Heo K, Baek HJ, Roeder RG, An W.

J Mol Biol. 2012 Feb 3;415(5):843-54. doi: 10.1016/j.jmb.2011.12.001. Epub 2011 Dec 9.

4.

Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML.

Link DC, Schuettpelz LG, Shen D, Wang J, Walter MJ, Kulkarni S, Payton JE, Ivanovich J, Goodfellow PJ, Le Beau M, Koboldt DC, Dooling DJ, Fulton RS, Bender RH, Fulton LL, Delehaunty KD, Fronick CC, Appelbaum EL, Schmidt H, Abbott R, O'Laughlin M, Chen K, McLellan MD, Varghese N, Nagarajan R, Heath S, Graubert TA, Ding L, Ley TJ, Zambetti GP, Wilson RK, Mardis ER.

JAMA. 2011 Apr 20;305(15):1568-76. doi: 10.1001/jama.2011.473.

5.
6.

Discovering multiple realistic TFBS motifs based on a generalized model.

Chan TM, Li G, Leung KS, Lee KH.

BMC Bioinformatics. 2009 Oct 7;10:321. doi: 10.1186/1471-2105-10-321.

7.

Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma.

Russell-Swetek A, West AN, Mintern JE, Jenkins J, Rodriguez-Galindo C, Ribeiro R, Zambetti GP.

J Med Genet. 2008 Sep;45(9):603-6. doi: 10.1136/jmg.2008.059568.

8.

Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human colon carcinoma LoVo/5-FU cells.

Yu ZW, Zhao P, Liu M, Dong XS, Tao J, Yao XQ, Yin XH, Li Y, Fu SB.

World J Gastroenterol. 2004 Jul 1;10(13):1979-83.

9.

Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses.

Damania B, Jeong JH, Bowser BS, DeWire SM, Staudt MR, Dittmer DP.

J Virol. 2004 May;78(10):5491-9.

11.

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, DeLacerda L, Rabin M, Cadwell C, Sampaio G, Cat I, Stratakis CA, Sandrini R.

Proc Natl Acad Sci U S A. 2001 Jul 31;98(16):9330-5.

12.

DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53.

Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R, Wang XW, Yokota J, Riabowol K, Harris CC.

Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9671-6. Epub 2001 Jul 31.

14.

Dial 9-1-1 for p53: mechanisms of p53 activation by cellular stress.

Ljungman M.

Neoplasia. 2000 May-Jun;2(3):208-25. Review.

15.

The tumor suppressor p53 can both stimulate and inhibit ultraviolet light-induced apoptosis.

McKay BC, Chen F, Perumalswami CR, Zhang F, Ljungman M.

Mol Biol Cell. 2000 Aug;11(8):2543-51.

16.

Repression of RNA polymerase I transcription by the tumor suppressor p53.

Zhai W, Comai L.

Mol Cell Biol. 2000 Aug;20(16):5930-8.

17.

ei24, a p53 response gene involved in growth suppression and apoptosis.

Gu Z, Flemington C, Chittenden T, Zambetti GP.

Mol Cell Biol. 2000 Jan;20(1):233-41.

19.

p53-mediated repression of alpha-fetoprotein gene expression by specific DNA binding.

Lee KC, Crowe AJ, Barton MC.

Mol Cell Biol. 1999 Feb;19(2):1279-88.

20.

Regulation of the mdm2 oncogene by thyroid hormone receptor.

Qi JS, Yuan Y, Desai-Yajnik V, Samuels HH.

Mol Cell Biol. 1999 Jan;19(1):864-72.

Supplemental Content

Support Center